Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N Iu Mironov"'
Autor:
E B Maĭkov, Iu A Iuricheva, N Iu Mironov, S F Sokolov, S P Golitsyn, L V Rozenshtraukh, E I Chazov
Publikováno v:
Терапевтический архив, Vol 87, Iss 1, Pp 38-48 (2015)
Aim. To evaluate the efficacy and safety of refralon (niferidil), a new class III antiarrhythmic agent whose activity is related to the block of delayed rectifying potassium current and to the prolongation of atrial and ventricular action potential a
Externí odkaz:
https://doaj.org/article/a061fcf2ee1442eebc93d2a1c3d4dd61
Autor:
E I Chazov, N Iu Mironov, Sergey P. Golitsyn, Maĭkov Eb, Iu A Iuricheva, Rozenshtraukh Lv, S. F. Sokolov
Publikováno v:
Kardiologiia. 54(1)
This article reviews experimental and clinical studies of a novel antiarrhythmic agent niferidile. Niferidile, a class III antiarrhythmic agent, blocks potassium outward currents, prolongs repolarization and refractory periods predominantly in atria
Autor:
N Iu, Mironov, S P, Golitsyn
Publikováno v:
Kardiologiia. 53(11)
Potassium channels and currents play essential roles in cardiac repolarization. Potassium channel blockade by class III antiarrhythmic drugs prolongs cardiac repolarization and results in termination and prevention of cardiac arrhythmias. Excessive i
Autor:
N Iu, Mironov, S P, Golitsyn, S F, Sokolov, E B, Maĭkov, N B, Shlevkov, Iu A, Iuricheva, Iu V, Mareev, L V, Rosenshtraukh, E I, Chazov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 75(10)
Intracardiac electrophysiological effects and antiarrhythmic activity of novel domestic class III antiarrhythmogenic drug niferidil has been studied in a group of 25 patients with paroxismal supraventricular tachycardia (PSVT) diagnosis. The drug was
Autor:
N Iu, Mironov, V V, Churiukanov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 69(5)
Transient receptor potential vanilloid (TRPV1), representing ion channel family, is activated in human and animal organism by capsaicin and some other factors such as heat, acidosis, and ion dysbalance. TRPV1 is a component of the endogenous system r